Federal contract receipt

$67,400,676 from Department of Health and Human Services to EMERGENT BIODEFENSE OPERATIONS LANSING LLC

CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL

Signals

Sole sourceNot competedLarge awardMulti-year performance

Office of Federal Procurement Policy

Public Spend Intelligence - sledai.com

Award #CONT_AWD_75A50122C00047_7505_-NONE-_-NONE-

Signed2024-09-19

PlaceNC

CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL

Total obligated$67,400,676.00

PoP Start

2022-08-29

PoP End

2028-10-01

SOLE SOURCE

Awarded on 2024-09-19